CONMED CNMD Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Product | ||||||
| General Surgery | $169.38M-21.5% | $215.82M+8.1% | $199.73M-0.9% | $201.61M+10.2% | $182.97M-11.6% | |
| Orthopedic Surgery | $147.66M-6.2% | $157.38M+13.9% | $138.19M-1.8% | $140.73M+1.8% | $138.29M-0.5% | |
| Net Sales by Geography | ||||||
| Americas (excluding the United States) | $32.9M-1.3% | $33.34M+6.0% | $31.44M-1.4% | $31.88M+5.9% | $30.11M+0.5% | |
| Asia Pacific | $41.96M-29.0% | $59.1M+9.8% | $53.83M+3.4% | $52.08M+19.1% | $43.71M-12.0% | |
| Europe, Middle East & Africa | $69.14M-7.2% | $74.52M+27.0% | $58.68M-13.4% | $67.78M+6.4% | $63.68M+1.1% | |
| United States | $173.06M-16.1% | $206.24M+6.3% | $193.98M+1.8% | $190.61M+3.7% | $183.76M-9.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CONMED break its business down?
- CONMED (CNMD) reports net sales by product across 2 parts — General Surgery and Orthopedic Surgery. Each is extracted from the segment footnotes and tracked over time.
- Where does CONMED's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CONMED's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
